Results 1 to 10 of about 7,886 (231)
EPIDEMIOLOGY OF PARACOCCIDIOIDOMYCOSIS [PDF]
Revista do Instituto de Medicina Tropical de São Paulo, 2015 SUMMARYThe epidemiological characteristics of paracoccidioidomycosis were reviewed and updated. The new endemic areas in Brazil were discussed in the section regarding the geographic distribution of the mycosis.
Roberto MARTINEZ
doaj +5 more sources
Journal of Fungi, 2022 Paracoccidioidomycosis (PCM) is the most prevalent systemic mycosis in Brazil. The disease is caused by dimorphic fungi nested within the Paracoccidioides genus.
Alessandra G. Krakhecke-Teixeira +10 more
doaj +2 more sources
Antigenemia in paracoccidioidomycosis [PDF]
Journal of Clinical Microbiology, 1992 Severe forms of paracoccidioidomycosis (Pcm) are accompanied by intense immunological involvement characterized by depression of the cell-mediated immune response and by high levels of antibodies in serum with no protective function. These changes can be reversed by antifungal treatment.
Gilson Freitas-da-Silva +1 more
openalex +4 more sources
PARACOCCIDIOIDOMYCOSIS TREATMENT [PDF]
Revista do Instituto de Medicina Tropical de São Paulo, 2015 SUMMARYConsidered to be an emerging endemic mycosis in Latin America, paracoccidioidomycosis is characterized by a chronic course and involvement of multiple organs in immunocompromised hosts. Infection sequelae are mainly related to pulmonary and adrenal insufficiency.
Maria Aparecida Shikanai‐Yasuda
openalex +5 more sources
mSystems, 2020 Brazil and many other Latin American countries are areas of endemicity for different neglected diseases, and the fungal infection paracoccidioidomycosis (PCM) is one of them. Among the clinical manifestations, pneumopathy associated with skin and mucosal
Estela de Oliveira Lima +12 more
doaj +2 more sources
Revista da Sociedade Brasileira de Medicina Tropical, 2018 Paracoccidioidomycosis is an endemic disease in Latin America that is rarely associated with immunosuppression and biological therapy. Herein, we report for the first time a case of pulmonary paracoccidioidomycosis reactivation after infliximab treatment.
Lúcia Carla Polaco Covre +4 more
doaj +2 more sources
Paracoccidioidomycosis in Immunocompromised Patients: A Literature Review
Journal of Fungi, 2018 Paracoccidioidomycosis (PCM) is an endemic mycosis found in Latin America that causes systemic disease mostly in immunocompetent hosts. A small percentage of PCM occurs in immunocompromised patients where low clinical suspicion of the infection, late ...
João N. de Almeida +2 more
doaj +2 more sources
Paracoccidioidomycosis after eyebrow micropigmentation: Unusual reactivation or a new form of transmission by cutaneous inoculation? [PDF]
Medical Mycology Case ReportsWe report a case of unusual paracoccidioidomycosis reactivation after eyebrow micropigmentation in a Brazilian patient. The cutaneous lesion was the only clinical manifestation. Direct cutaneous inoculation in dermal tissues with Paracoccidioides sp.
Vítor Falcão de Oliveira +4 more
doaj +2 more sources
Treatment compliance of patients with paracoccidioidomycosis in Central-West Brazil
Jornal Brasileiro de Pneumologia, 2019 Objective: To evaluate the treatment compliance of patients with paracoccidioidomycosis. Methods: We studied 188 patients with paracoccidioidomycosis admitted to a tertiary referral hospital in the Central-West Region of Brazil from 2000 to 2010, to ...
Ursulla Vilella Andrade +7 more
doaj +2 more sources
Paracoccidioidomycosis – description of two cases autochthonous in Ceará
Brazilian Journal of Infectious Diseases, 2010 Paracoccidioidomycosis is endemic in most countries of Latin America. Brazil has the greatest number of cases, with no autochthonous case registered in the state of Ceará. The cases of two patients that had never gone outside the State of Ceará and lived
Mônica Cardoso Façanha +3 more
doaj +2 more sources